Cisd2tm1b(EUCOMM)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Cisd2tm1b(EUCOMM)Wtsi |
| Name: |
CDGSH iron sulfur domain 2; targeted mutation 1b, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:8350101 |
| Gene: |
Cisd2 Location: Chr3:135112173-135129194 bp, - strand Genetic Position: Chr3, 62.55 cM, cytoband H2
|
| Alliance: |
Cisd2tm1b(EUCOMM)Wtsi page
|
| IMPC: |
Cisd2 gene page |
|
| Mutant Cell Line: |
EPD0143_2_C03 |
| Germline Transmission: |
Earliest citation of germline transmission:
J:361968
|
| Parent Cell Line: |
JM8.N4 (ES Cell)
|
| Strain of Origin: |
C57BL/6N
|
| Project Collection: |
EUCOMM
|
|
| Allele Type: |
|
Targeted (Null/knockout, Reporter) |
| Mutation: |
|
Intragenic deletion
Vector: L1L2_Bact_P
|
| |
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 135116504 of Chromosome 3 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 135117472. The critical exon(s) is/are thus flanked by loxP sites. Cre expression occurs without flp expression created a reporter knockout mouse. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:361968)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Cisd2 Mutation: |
38 strains or lines available
|
|
| Original: |
J:361968 Mary Lyon Centre at MRC Harwell, Direct data submission from Mary Lyon Centre at MRC Harwell. 2025; |
| All: |
1 reference(s) |
|